Loading...
Ibere Pharmaceuticals
IBER•NYSE
Financial Services
Shell Companies
$10.18
$-0.02(-0.20%)
Ibere Pharmaceuticals (IBER) Company Profile & Overview
Explore Ibere Pharmaceuticals’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Ibere Pharmaceuticals (IBER) Company Profile & Overview
Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.
SectorFinancial Services
IndustryShell Companies
CEOOsagie O. Imasogie
Contact Information
Company Facts
CountryUS